The American Diabetes Association (ADA) 76th Scientific Sessions will be held in New Orleans, LA from June 10-14, 2016. Abstracts will not be on line until June 3 after 5 PM EST. The most notable presentation this year is data from GLP-1 agonist Victoza's (NVO) cardiovascular outcomes trial (CVOT). The SGLT2 inhibitor Jardiance (Boehringer, LLY), which had positive data from its CVOT released at conferences last year, will have an update at the ADA, and it will be quite interesting to compare results from the trials. While Jardiance’s benefit on its primary endpoint was mostly derived from a reduction in CV death, Novo Nordisk stated that all three components of the endpoint (CV death, non-fatal myocardial infarction and non-fatal stroke) contributed to Victoza's overall reduction in CV risk. There will also be first Phase III data or first conference presentations from a number of drugs or studies, including ertugliflozin (MRK, PFE), semaglutide's SUSTAIN 2 and 3 (NVO), ITCA 650's FREEDOM-2 (Intarcia, Servier), the biosimilar insulins MK-1293 (MRK) and SAR342434 (SNY), and faster-acting insulin aspart (NVO). Drugs/Devices Highlighted:

• GLP-1 Agonists versus SGLT2 Inhibitors, CVOTs and Renal Effects: Victoza (NVO), Jardiance (Boehringer, LLY), Invokana (JNJ)


• Other SGLT2 Inhibitor Highlights: Ertugliflozin (MRK, PFE), Farxiga (AZN), Invokana (JNJ)


• Other GLP-1 Agonist Highlights: Semaglutide (NVO), ITCA 650 (Intarcia, Servier), Victoza (NVO)


• GLP-1 Agonist – Insulin Combination Treatment: Xultophy (NVO), LixiLan (SNY)


• Insulins: MK-1293 (MRK), SAR342434 (SNY), Tresiba (NVO), faster-acting insulin aspart (NVO), BioChaperone lispro (LLY, Adocia)


• Early Stage Drugs: MEDI4166 (AZN), MK-8666 (MRK), PF-06293620 (PFE), PF-06291874 (PFE)


• Devices: Dexcom CGM

To download the full conference planner in PDF, click the link at the top of the page. The support material includes a full Excel planner that allows you to select presentations/posters and then automatically create your own printable planner. It also includes potentially notable presentations/posters, primarily clinical, selected by our analysts. If you have already selected presentations on the ADA itinerary planner and would like to format them like our Excel planner, please contact askanalyst@sagientresearch.com. For our disclosures, please read the Biomedtracker Research Standards.